Scarica l'app Stockscreener
22.75
1.61%
0.36
Pre-mercato:
22.69
-0.06
-0.26%
Precedente Chiudi:
$22.39
Aprire:
$22.37
Volume 24 ore:
3.88M
Relative Volume:
0.80
Capitalizzazione di mercato:
$11.36B
Reddito:
$4.72B
Utile/perdita netta:
$-232.00M
Rapporto P/E:
-48.79
EPS:
-0.4663
Flusso di cassa netto:
$284.00M
1 W Prestazione:
-3.93%
1M Prestazione:
-8.63%
6M Prestazione:
+3.17%
1 anno Prestazione:
+140.49%
Intervallo 1D:
$22.08
$22.78
Intervallo di 1 settimana:
$21.76
$23.85
Portata 52W:
$9.26
$27.72
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.75 | 11.36B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
16.63 | 52.54B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
116.87 | 49.15B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.58 | 42.62B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.64 | 35.68B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
567.16 | 24.86B | 3.18B | 1.33B | 1.04B | 27.90 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-01-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | Aggiornamento | Argus | Hold → Buy |
| 2025-10-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-07-17 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Veterinary care chain NVA taps Todd Young, former Acadia CFO - Stock Titan
Elanco Animal Health moves into new downtown Indianapolis headquarters - MSN
Winners And Losers Of Q4: Elanco (NYSE:ELAN) Vs The Rest Of The Pharmaceuticals Stocks - Yahoo Finance
ELAN Stock Price, Quote & Chart | ELANCO ANIMAL HEALTH INC (NYSE:ELAN) - ChartMill
Dog-Shaped Furniture Sets - Trend Hunter
Elanco Animal Health (XTER:5EA) Short-term investments - GuruFocus
Is Elanco Animal Health (ELAN) Still Attractive After A 154% One Year Share Price Surge - simplywall.st
ELAN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Elanco Animal Health Inc (ELAN) Shares Fall 4.5% -- What GF Scor - GuruFocus
Elanco (NYSE: ELAN) CEO receives new deferred stock unit grant - Stock Titan
Elanco (ELAN) CFO receives new deferred stock unit award in Form 4 filing - Stock Titan
Elanco (NYSE: ELAN) officer awarded new Deferred Stock Units grant - Stock Titan
Stifel Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Climate-neutral meat may be less than 10 years off, Elanco CEO says - Semafor
Elanco Animal Health Incorporated $ELAN Position Decreased by Davidson Investment Advisors - MarketBeat
Elanco Animal Health (NYSE:ELAN) Downgraded by Wall Street Zen to Buy - MarketBeat
174,412 Shares in Elanco Animal Health Incorporated $ELAN Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
Elanco Animal Health Price Target Announced at $30.00/Share by Citigroup - Moomoo
Citi Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Elanco Confirms Date and Conference Call for First Quarter 2026 Financial Results Announcement - Financial Times
Elanco Animal Health Inc (ELAN) Shares Fall 3.6% -- GF Value Says Still Overvalued - GuruFocus
ELAN Initiated Coverage by Citigroup -- Price Target Announced a - GuruFocus
Citi Initiates Elanco Animal Health(ELAN.US) With Buy Rating, Announces Target Price $30 - Moomoo
Is Elanco (ELAN) Using Mass-Market Collars to Quietly Redefine Its Companion Animal Strategy? - Yahoo Finance
Is It Too Late To Consider Elanco Animal Health (ELAN) After Its 1-Year Share Price Surge? - Yahoo Finance
Animal Health Market Intelligence Report 2026-2034 Featuring Strategic Analysis of Bayer, Elanco, Merck, Merial, Zoetis, Boehringer Ingelheim, Ceva Sante Animale, Heska and More - Yahoo Finance
Citigroup Begins Coverage on Elanco Animal Health (NYSE:ELAN) - MarketBeat
Elanco Animal Health: Leading With Innovation, Impact, and Purpose - marketscreener.com
Elanco Animal Health Incorporated (NYSE:ELAN) Short Interest Up 49.0% in March - MarketBeat
630,840 Shares in Elanco Animal Health Incorporated $ELAN Acquired by Hardman Johnston Global Advisors LLC - MarketBeat
Elanco Animal Health Inc Investor Day Transcript - GuruFocus
Q3 2025 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Institution Moves: Is Elanco Animal Health Incorporated gaining market shareEarnings Performance Report & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Where is Elanco Animal Health Incorporated (ELAN) headed according to the Street? - MSN
DDD Partners LLC Decreases Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Douglas Lane & Associates LLC - MarketBeat
Elanco Animal Health Inc (STU:5EA) Bonds - GuruFocus
Elanco Animal Health Incorporat (ELAN) Stock forecasts - Yahoo Finance UK
Dimensional Fund Advisors (NYSE: ELAN) reports 24.5M shares beneficially owned - Stock Titan
Elanco Launches Advantage Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* - Finviz
Elanco Animal Health Inc (ELAN) Shares Gap Down to $22.82 on Apr 9 - GuruFocus
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes* - PR Newswire
Aug Sectors: Can Elanco Animal Health Incorporated expand its profit marginsLayoff News & Weekly Market Pulse Alerts - baoquankhu1.vn
Form DEF 14A Elanco Animal Health For: Dec 31 - StreetInsider
[DEF 14A] Elanco Animal Health Inc Definitive Proxy Statement - Stock Titan
BofA Securities Maintains Elanco Animal Health(ELAN.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Elanco (ELAN) executive awarded new deferred stock units under deferral plan - Stock Titan
Elanco (NYSE: ELAN) CEO awarded new deferred stock units as compensation - Stock Titan
Elanco (ELAN) CFO awarded new deferred stock units in Form 4 filing - Stock Titan
Elanco (ELAN) officer granted 40,985 shares, with 20,288 withheld for taxes - Stock Titan
Stifel reiterates buy on Elanco stock, keeps $32 price target - Investing.com
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Elanco Animal Health Inc Azioni (ELAN) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Modi Rajeev A. | SEE REMARKS |
Dec 11 '25 |
Buy |
21.33 |
4,500 |
95,985 |
123,082 |
| VanHimbergen Robert M | EVP and CFO |
Dec 11 '25 |
Buy |
21.64 |
6,950 |
150,426 |
124,233 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Dec 11 '25 |
Buy |
21.75 |
22,000 |
478,496 |
167,000 |
0.66%
1.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):